Coloplast announces foundation control change. Coloplast stock costs EUR 55.33.
Published on 10/04/2026 at 17:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
On October 1, 2026, Coloplast A/S announced that it had received a major shareholder notification concerning a change in the ultimate ownership structure. The announcement said Coloplast Fonden, through its wholly owned subsidiary CF Holding af 2026 ApS, indirectly controls 51.36 percent of the voting rights in Coloplast A/S and indirectly holds 18.46 percent of its share capital. The details were published in a Coloplast A/S release distributed by GlobeNewswire.
At 5:45 p.m. CEST on October 4, 2026, Coloplast stock stood at EUR 55.33 in weekend trading at Lang & Schwarz. That matched the close at Lang & Schwarz on October 2, 2026, also EUR 55.33.
Weekend trading at Lang & Schwarz
The quoted bid was EUR 55.26 and the ask was EUR 55.40. The price was unchanged against the October 2 close at Lang & Schwarz. The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Coloplast stock.
Ownership transition
The company said NPLH Holding ApS transferred all its shares in Coloplast Holding ApS to Coloplast Fonden as a gift. Coloplast Fonden then contributed those shares to CF Holding af 2026 ApS. Coloplast Holding ApS holds 51.36 percent of the voting rights and 29.49 percent of the share capital in Coloplast A/S, according to the company announcement.
Next Xetra session
The next Xetra session is scheduled for October 5, 2026. The October 4 quote remains a weekend-trading indication from Lang & Schwarz while Xetra and the primary exchanges are closed.
